Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 164

Belluscura harnesses Nanotether Discovery Science

Cardiff spinout Nanotether Discovery Science has been acquired for $340,000.

Apr 28, 2017

SiriusXM goes Automatic in $100m acquisition

The online radio group has bought in-car connected technology developer Automatic Labs, giving exits to Comcast, CDK Global and USAA among others.

Apr 28, 2017

Yik Yak gets Square deal in $3m acqui-hire

Square has reportedly paid $3m for the engineering team of microblogging platform Yik Yak, likely signalling the Renren-backed company is nearing the end of the line.

Apr 26, 2017

TeleSign signals Telstra exit through $230m acquisition

Bics has agreed to acquire TeleSign, which raised $49m in a 2014 Telstra-backed series B round, to form the world's first end-to-end communications-platform-as-a-service provider.

Apr 26, 2017

Microsoft to commission Cloudyn acquisition

Microsoft could pay up to $70m for the cloud optimisation platform, which has raised more than $20m in funding including $4m from Infosys last August.

Apr 25, 2017

Moat to form part of Oracle's structure

Oracle has agreed to acquire Moat, which had raised $67m since 2010 from backers including SoftBank Capital, for a reported $850m.

Apr 20, 2017

Walmart to iron out $300m Bonobos acquisition

Nordstrom and Coppel could exit the online men's fashion company, which is in talks with Walmart over an acquisition that would follow $127m of venture funding.

Apr 18, 2017

PetCoach gets a new owner

Petco has purchased petcare services platform PetCoach for an undisclosed sum, providing an exit to corporate investors Comcast and Pet360.

Apr 5, 2017

Grab pays up to $100m for Kudo

Grab has completed the acquisition of Emtek, Gree and Singapore Press Holdings-backed mobile payment portal Kudo for between $80m and $100m.

Apr 5, 2017

Vtesse accelerates to $200m acquisition

Sucampo has acquired the Lundbeck and Pfizer-backed rare diseases treatment developer for $200m in stock and cash, less than a year after it closed a $42m series A round.

Apr 4, 2017
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here